The activities listed below are made possible by the European Union. PROMPT (Personalised-care and Research On Motoric-dysfunctioning for Patient-specific Treatments) project receives a subsidy for the following activity(s): Development of an integrated system for the…
News
PROHEALTH project
The activities listed below are made possible by the European Union. PROHEALTH project receives a subsidy for the following activity(s): The development and validation of a wearable sensor for measuring cerebral blood flow are based…
PRESS RELEASE: Orikami Takes Over Multiple Screener From Sanofi
Nijmegen, June 28, 2021 Since June 1, 2021, Orikami is the new owner of The Multiple Screener, a cognitive test for MS developed by Sanofi. A new step in which Orikami continues to build on its…
PRESS RELEASE: Orikami brings in new investors
Nijmegen, May 31, 2021 As of May 2021, CbusineZ will join Orikami Group BV, alongside existing investor Healthy.Capital. Both investors enable Orikami to roll out the product MS sherpa to clinical practice and also accelerate…
Orikami Blogs
Our colleagues regularly dive into interesting and difficult topics to write down in detail in a blog. All our blogs are collected on this website.
New website as part of the new corporate identity
Welcome to the new Orikami website. With this new website we show more clearly what we stand for: as a Dutch MedTech organization we are committed to enable personalized healthcare by applied data science and…
Behind the screens: towards balance detection
We might not realize it, but we heavily rely on our balance. Only when our balance is compromised this dependency becomes clear. People with compromised balance control are more likely to fall and risk injuries…
More than meets the eye — pupil
Why do we need pupil detection methods? There is an upcoming trend of health smartphone apps that measure all kinds of personal data to provide insight into certain aspects of someone’s health. However, some health…